|
|
Other links at Articles > Gastroenterology |
| 2. |
Ursodeoxycholic Acid Might Help in Refractory HCV
|
|
|
Ursodeoxycholic acid (UDCA) may be of use in treatment of patients with chronic hepatitis C virus (HCV) who do not respond to therapy with combined pegylated interferon and ribavirin, Japanese researchers report in the December issue of Gut. Reuters Health Information
|
| 3. |
The Ethics of Phase I Trials of Biologic Agents
|
|
|
Early and limited exposure to biologics can cause antibodies to develop and, ultimately, prevent trial participants from gaining any treatment benefit. In this editorial, the author calls for the risks to be clearly stated.
Nature Clinical Practice Gastroenterology & Hepatology
|
|
|